1. Clinical Overview
Pramipexole is a non-ergot dopamine agonist that selectively stimulates dopamine D2, D3, and D4 receptors in the brain. It is a first-line treatment for Parkinson's disease (PD) and is also approved for Restless Legs Syndrome (RLS). The 0.375mg strength is a common therapeutic dose for PD, often used in the initial titration phase. It helps manage motor symptoms like bradykinesia, rigidity, and tremor by compensating for the dopamine deficiency in the nigrostriatal pathway.
| Onset | Duration | Bioavailability |
|---|---|---|
| Approximately 2 hours for peak plasma concentration; clinical effect on PD symptoms may be observed within a few days to weeks. | Approximately 8-12 hours, supporting a thrice-daily dosing regimen for Parkinson's disease. | >90% |
2. Mechanism of Action
Pramipexole exerts its therapeutic effects by directly stimulating postsynaptic dopamine receptors (D2 subfamily: D2, D3, D4) in the striatum. This action compensates for the depleted dopamine levels characteristic of Parkinson's disease, thereby improving motor function. For RLS, its mechanism is believed to involve modulation of dopaminergic pathways in the spinal cord and brain.
3. Indications & Uses
- Idiopathic Parkinson's Disease (as monotherapy or adjunct to levodopa)
- Moderate to Severe Primary Restless Legs Syndrome (RLS)
4. Dosage & Administration
Adult Dosage: Parkinson's Disease: Start at 0.125 mg TID. Titrate weekly by 0.125 mg TID to effective dose. Usual therapeutic range: 1.5-4.5 mg/day in 3 divided doses. RLS: Start at 0.125 mg once daily, 2-3 hours before bedtime. Titrate to 0.375 mg daily if needed after 4-7 days.
Administration: Take orally with or without food. Taking with food may reduce nausea. For RLS, take once daily 2-3 hours before bedtime. Do not crush or chew extended-release tablets (if applicable; 0.375mg is typically immediate-release). Swallow whole with water. Maintain a consistent dosing schedule.
5. Side Effects
Common side effects may include:
- Nausea
- Dizziness
- Somnolence (daytime sleepiness)
- Insomnia
- Constipation
- Peripheral edema
- Headache
- Fatigue
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Levodopa/Carbidopa | Increased dopaminergic effects and side effects (dyskinesia, nausea, hallucinations). Pramipexole may allow reduction of levodopa dose. | Major |
| Antipsychotics (e.g., Haloperidol, Risperidone) | Antagonism of dopaminergic effect, reducing efficacy of pramipexole. | Major |
| Metoclopramide, Domperidone | Domperidone (peripheral blocker) is safer. Metoclopramide (central D2 antagonist) may antagonize pramipexole's effect. | Moderate |
| Antihypertensives | Additive hypotensive effect, increasing risk of dizziness and syncope. | Moderate |
| Cimetidine | Reduces renal clearance of pramipexole by inhibiting tubular secretion, increasing pramipexole AUC by ~50%. Dose adjustment may be needed. | Moderate |
| Other CNS Depressants (Alcohol, Benzodiazepines, Opioids) | Additive sedative effects, increasing risk of somnolence and sleep attacks. | Major |
| Drugs eliminated via active renal secretion (e.g., Amantadine, Cimetidine, Ranitidine) | Potential for competition, altering plasma levels of either drug. | Moderate |
7. Patient Counselling
- DO take the medication exactly as prescribed. DO NOT stop suddenly; consult doctor for tapering.
- DO inform your doctor about all other medications, including OTC drugs.
- DO rise slowly from sitting/lying position to avoid dizziness.
- DO NOT drive or operate heavy machinery until you are sure the medicine does not make you drowsy.
- DO report any new or unusual urges (gambling, shopping, eating, sexual thoughts) to your doctor immediately.
- For RLS, take the dose 2-3 hours before your usual bedtime.
8. Toxicology & Storage
Overdose: Nausea, vomiting, hypotension, agitation, hallucinations, involuntary movements (dyskinesia), cardiac arrhythmias, and sedation progressing to coma.
Storage: Store below 30°C. Protect from light and moisture. Keep in the original blister pack or container. Keep out of reach of children. Do not use after the expiry date printed on the pack.